SCHEMBL24093309

SCHEMBL24093309

CC1(CC#N)CCN(Cc2cccc(SC(F)(F)F)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ UBE2M P61081 1/20 0.40
▸ DCUN1D1 Q96GG9 1/20 0.40
▸ TACR1 P25103 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ OPRM1 P35372 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ OPRL1 P41146 4/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CHRM4 P08173 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20781917 0.87 ALDH1A1 (0.42) ALDH1A1GAALMNANPSR1UBE2M
SCHEMBL19567427 0.86 ALDH1A1 (0.41) ALDH1A1GAALMNANPSR1UBE2M
SCHEMBL24093437 0.86 ALDH1A1 (0.47) ALDH1A1GAALMNANPSR1UBE2M
SCHEMBL19567425 0.86 USP2 (0.38) ALDH1A1LMNANPSR1KDM4EOPRM1
SCHEMBL23514773 0.86 ALDH1A1 (0.42) ALDH1A1GAALMNANPSR1UBE2M
SCHEMBL24093351 0.82 ALDH1A1 (0.58) ALDH1A1GAALMNANPSR1TACR1
SCHEMBL19567986 0.78 PRMT6 (0.56) OPRM1OPRL1JAK2JAK1KCNH2
SCHEMBL19568026 0.78 HTR2A (0.43) OPRM1OPRL1KCNH2
SCHEMBL19567216 0.78 SIGMAR1 (0.56) ALDH1A1GAAKDM4EOPRM1MEN1
SCHEMBL19567192 0.78 TACR1 (0.47) ALDH1A1TACR1JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
Send feedback